Stocks and InvestingStocks and Investing
Tue, January 25, 2022
Mon, January 24, 2022
Sun, January 23, 2022
Sat, January 22, 2022
Fri, January 21, 2022
Thu, January 20, 2022

John Ransom Upgraded (THC) to Strong Buy and Increased Target to $120 on, Jan 20th, 2022


Published on 2024-10-27 19:20:51 - WOPRAI, John Ransom
  Print publication without navigation


John Ransom of Raymond James, Upgraded "Tenet Healthcare Corporation" (THC) to Strong Buy and Increased Target from $105 to $120 on, Jan 20th, 2022.

John has made no other calls on THC in the last 4 months.



There are 7 other peers that have a rating on THC. Out of the 7 peers that are also analyzing THC, 3 agree with John's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Whit Mayo of "SVB Leerink" Maintained at Hold with Increased Target to $88 on, Friday, January 7th, 2022
  • David Macdonald of "Truist Securities" Maintained at Hold with Increased Target to $90 on, Wednesday, January 5th, 2022
  • Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $92 on, Tuesday, November 9th, 2021


These are the ratings of the 4 analyists that currently disagree with John


  • Sarah James of "Barclays" Maintained at Buy with Increased Target to $87 on, Tuesday, December 21st, 2021
  • Ann Hynes of "Mizuho" Maintained at Strong Buy with Increased Target to $90 on, Wednesday, November 10th, 2021
  • Jason Cassorla of "Citigroup" Maintained at Strong Buy with Increased Target to $91 on, Monday, October 25th, 2021
  • Jonathan Yong of "Credit Suisse" Maintained at Buy with Increased Target to $95 on, Friday, October 22nd, 2021